Evonik Industries AG (MIL:1EVK)

€ 17.935 0 (0%) Market Cap: 8.35 Bil Enterprise Value: 11.56 Bil PE Ratio: 37.13 PB Ratio: 0.92 GF Score: 71/100

Q3 2024 Evonik Industries AG Earnings Call Transcript
Nov 06, 2024

€18.81 (-6.56%)

Earnings
Q2 2024 Evonik Industries AG Earnings Call Transcript
Aug 01, 2024

€19.09 (+0.95%)

Earnings
Q1 2024 Evonik Industries AG Earnings Call Transcript
May 08, 2024

€20.35

Earnings
Q4 2023 Evonik Industries AG Earnings Call Transcript
Mar 04, 2024

€17.11

Earnings
Q3 2023 Evonik Industries AG Earnings Call Transcript
Nov 07, 2023

€17.76 (+7.67%)

Earnings
Q2 2023 Evonik Industries AG Earnings Call Transcript
Aug 10, 2023

€18.94 (+2.41%)

Earnings
Evonik Industries AG Annual Shareholders Meeting Transcript
May 31, 2023
Q1 2023 Evonik Industries AG Earnings Call Transcript
May 09, 2023

€19.45 (-1.17%)

Earnings
Q4 2022 Evonik Industries AG Earnings Call Transcript
Mar 02, 2023

€20.2

Earnings
Q3 2022 Evonik Industries AG Earnings Call Transcript
Nov 08, 2022

€18.33

Earnings
Q2 2022 Evonik Industries AG Earnings Call Transcript
Aug 10, 2022

€20.52 (-1.72%)

Earnings
Q1 2022 Evonik Industries AG Earnings Call and Capital Markets Day Transcript
May 11, 2022

€24.7

Earnings
Full Year 2021 Evonik Industries AG Earnings Call Transcript
Mar 03, 2022

€25.38 (-12.90%)

Earnings
Q3 2021 Evonik Industries AG Earnings Call Transcript
Nov 04, 2021

€27.99 (-0.92%)

Earnings
Q2 2021 Evonik Industries AG Earnings Call Transcript
Aug 05, 2021

€28.73 (-1.61%)

Earnings
Evonik Industries AG Nutrition & Care and Smart Materials - Specialty Additives Call (Virtual) Transcript
Jul 01, 2021
Evonik Industries AG Division Spotlight Series Smart Materials Call Transcript
Jun 24, 2021
Evonik Industries AG Annual Shareholders Meeting Transcript
Jun 02, 2021
Q1 2021 Evonik Industries AG Earnings Call Transcript
May 06, 2021

€30.05 (+3.66%)

Earnings
Evonik Industries AG Division Spotlight Series Transcript
Apr 13, 2021
Full Year 2020 Evonik Industries AG Earnings Call Transcript
Mar 04, 2021

€28.93 (+2.05%)

Earnings
Q3 2020 Evonik Industries AG Earnings Call Transcript
Nov 03, 2020

€21.62 (-5.42%)

Earnings
Evonik Industries AG Annual Shareholders Meeting Transcript
Aug 31, 2020
Q2 2020 Evonik Industries AG Earnings Call Transcript
Aug 04, 2020

€23.85

Earnings
Q1 2020 Evonik Industries AG Earnings Call and Capital Markets Day Transcript
May 07, 2020

€18.4

Earnings
Full Year 2019 Evonik Industries AG Earnings Call Transcript
Mar 04, 2020

€26.13

Earnings
Q3 2019 Evonik Industries AG Earnings Call Transcript
Nov 05, 2019

€24.49

Earnings
Q2 2019 Evonik Industries AG Earnings Call Transcript
Aug 01, 2019

€24.84 (-4.83%)

Earnings
Evonik Industries AG Annual Shareholders Meeting Transcript
May 28, 2019
Q1 2019 Evonik Industries AG Earnings Call Transcript
May 07, 2019

€26.28

Earnings
Full Year 2018 Evonik Industries AG Earnings Call Transcript
Mar 05, 2019

€24.67

Earnings

Evonik Industries AG Division Spotlight Series Smart Materials Call Transcript

Jun 24, 2021 / 01:00PM GMT

Release Date Price: €28.4

Transcript

Tim Lange

Evonik Industries AG - Head of IR

Yes please stay connected. This is the right event. It's not the Paris Fashion Show. It's the second division spotlight series event. Welcome to Evonik, welcome to Essen to all of you out at the screens. These fancy shoes that you've just seen are only the one-off many examples of smart solutions products that you will get to know today, and my colleagues will give you all the details in a second on the shoes and the other highlights of today.

It's about 2 months that we have hosted first part of our division spotlight on Nutrition & Care. And since then, the division has executed on their strategy as promised. They have ramped up the lipid nano particular production in Hanau in Germany in record time and started delivering to BioNTech. And they have signed an agreement with Stanford University on polymer-based messenger RNA delivery technology. And recently, they have acquired Infinitech, a company for novel active ingredients for cosmetic applications. So these are the next steps for the division in executing their strategy. And with that, we

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.